Chirurgia Cancerului Gastric--Analiza A 110 Cazuri

Popescu, B.; Iordache, F.; Turculeţ, C.; Vartic, Mihaela; Beuran, M.
January 2014
Jurnalul de Chirurgie;2014, Vol. 10 Issue 1, p49
Academic Journal
Introduction: The current trend for the modern treatment of gastric cancer it is represented by radical surgery with extended lymphadenectomy. The lymphadenectomy, as defined by the Japanese surgeons, is an important, already proved, marker for the overall and disease free survival, but is associated with a risk of postoperative morbidity and mortality. Aim: The aim of the study was to analyze the gastric cancer surgery evaluating the postoperative morbidity and mortality. Material and Method: We performed an observational study, on 110 patients with gastric cancer operated in the Emergency Clinical Hospital Bucureşti. We also included in our study the tumors located at the gastro-oesophageal junction (that proved by histopathology exam to be of gastric origin) and the tumors of the remnant stomach. RESULTS: The men to women ratio was 1.5 and the mean age was 65.02 ± 11.04 years old. The gastric cancer is located in the 1/3rd upper part in 20.90% cases, and on the distal 2/3rd in 68.17%. Almost half of the patients (48.18%) were admitted with complications (bleeding, stenosis and/or perforation). 25.54% from the patients had distant metastasis (liver, peritoneum, pulmonary, or/and lymphnodes). All the cases were advanced or locally advanced gastric cancer and no case of early gastric cancer has been noted. Most of our surgical interventions were standard resections: total or distal gastrectomy associated with D1 lymphadenectomy in 64 cases and D2 in 32 cases. The mean operative time was 182.3 ± 99 minutes. The overall mortality rate was of 4.5%. The type of lymphadenectomy wasn't a risk factor for postoperative mortality. Conclusions: The gastric cancer is diagnosed, most commonly, in an advance stage. However, the trend is to perform radical or potentially radical gastrectomies associated with D1 or D2 lymphadenectomy. The type of lymphadenectomy is not a risk factor for postoperative morbidity and mortality.


Related Articles

  • Additional Gastrectomy after Endoscopic Submucosal Dissection for Early Gastric Cancer Patients with Comorbidities. Naohiko Koide; Daisuke Takeuchi; Akira Suzuki; Satoshi Ishizone; Shinichi Miyagawa // International Journal of Surgical Oncology;2012, p1 

    Purpose. We investigated the clinicopathologic features of early gastric cancer (EGC) patients who have undergone additional gastrectomy after endoscopic submucosal dissection (ESD) because of their comorbidities. Methods. Eighteen (7.1%) of 252GC patients were gastrectomized after prior ESD....

  • Ultrasonic Scalpel for Gastric Cancer Surgery: a Prospective Randomized Study. Inoue, Kentaro; Nakane, Yasushi; Michiura, Taku; Yamada, Masanori; Mukaide, Hiromi; Fukui, Junichi; Miki, Hirokazu; Ueyama, Yosuke; Nakatake, Richi; Tokuhara, Katsuji; Iwamoto, Shigeyoshi; Yanagimoto, Hiroaki; Toyokawa, Hideyoshi; Satoi, Sohei; Kwon, A-Hon // Journal of Gastrointestinal Surgery;Oct2012, Vol. 16 Issue 10, p1840 

    Background: The aim of the study was to evaluate the potential advantages of the ultrasonic scalpel compared with the conventional technique in gastric cancer surgery. Methods: Patients with resectable adenocarcinoma of the stomach were randomly assigned to ultrasonic scalpel or conventional...

  • Perioperative or postoperative therapy for resectable gastric cancer? Labianca, R.; Sburlati, P.; Quadri, A.; Garassino, M. C. // Annals of Oncology;Jun2008 Supplement 5, Vol. 19, pv99 

    The article examines issues related to the use of perioperative or postoperative therapy for resectable gastric cancer. It compares different approaches to lymph node dissection in Asian and Western surgeons and the potential advantage of extended lymphadenectomy in gastric cancer patients. It...

  • Huge effect of arginine on survival in gastric cancer? Lassen, Kristoffer; Mortensen, Kim; Griffiths, Ewen; Johna, Samir; Nilsson, Magnus // Journal of Cancer Research & Clinical Oncology;Apr2014, Vol. 140 Issue 4, p685 

    No abstract available.

  • Therapie des Magenkarzinoms über die aktuelle Leitlinie hinaus. Schuhmacher, C.; Novotny, A.; Meyer, H.-J. // Der Chirurg;Apr2013, Vol. 84 Issue 4, p310 

    The majority of recommendations in the current S3 guideline on the diagnosis and treatment of gastric carcinoma are based on good clinical practice and lack supporting randomized studies. With the development of endoscopic resection and multimodal treatment concepts, pretherapeutic tumor staging...

  • Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection. Sato, Hirohiko; Shimada, Mitsuo; Kurita, Nobuhiro; Iwata, Takashi; Nishioka, Masanori; Morimoto, Shinya; Yoshikawa, Kozo; Miyatani, Tomohiko; Goto, Masakazu; Kashihara, Hideya; Takasu, Chie // Surgical Endoscopy;Aug2012, Vol. 26 Issue 8, p2240 

    Background: Laparoscopy-assisted gastrectomy (LAG) is becoming widely used for early gastric cancer. However, how the curability and long-term prognosis of LAG and open gastrectomy (OG) for early and advanced gastric cancer compare remains unclear. This study assessed short- and long-term...

  • Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy. Snyder, R. A.; Castaldo, E. T.; Bailey, C. E.; Phillips, S. E.; Chakravarthy, A. B.; Merchant, N. B. // International Journal of Surgical Oncology;2012, p1 

    Purpose. Although randomized trials suggest a survival benefit of adjuvant chemotherapy and radiation therapy (XRT) for gastric adenocarcinoma, its use in patients who undergo an extended lymphadenectomy is less clear. The purpose of this study was to determine if a survival benefit exists in...

  • Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893]. Hyoung-Il Kim; Hoon Hur; Youn Nam Kim; Hyuk-Joon Lee; Min-Chan Kim; Sang-Uk Han; Woo Jin Hyung // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Extended systemic lymphadenectomy (D2) is standard procedure for surgical treatment of advanced gastric cancer (AGC) although less extensive lymphadenectomy (D1) can be applied to early gastric cancer. Complete D2 lymphadenectomy is the mandatory procedure for studies that evaluate...

  • Laparoscopy distinctive technique for suprapancreatic lymph node dissection: medial approach for laparoscopic gastric cancer surgery. Kanaya, Seiichiro; Haruta, Shusuke; Kawamura, Yuichiro; Yoshimura, Fumihiro; Inaba, Kazuki; Hiramatsu, Yoshihiro; Ishida, Yoshinori; Taniguchi, Keizo; Isogaki, Jun; Uyama, Ichiro // Surgical Endoscopy;Dec2011, Vol. 25 Issue 12, p3928 

    Background: Suprapancreatic lymph node (LN) dissection is critical for gastric cancer surgery. Until currently, a number of laparoscopic gastrectomy procedures have been performed in the same manner as open surgery procedures [, , ]. Using the characteristic of laparoscopic surgery, the authors...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics